BSEBoard Meeting3d ago · 6 Nov 2026, 01:22 pm

Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. To consider and approve the Unaudited Financial Result of the Company for the Quarter and half year ended on 30th September 2026; 2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the ....

Choksi Laboratories Ltd · 526546

✦ AI SummaryResults

Choksi Laboratories Ltd has scheduled a Board of Directors meeting on November 14, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026, and other items.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Choksi Laboratories Ltd - 526546 - Board Meeting Intimation for Meeting Of Board Of Directors Of The Company To Be Held On 14.11.2026

Attachments (1)

📄

8cfe6f2f-d2ba-4bbd-82ca-1177fd190210.pdf

pdf

Download →
View document text
C orporate Office & Central Laboratory R/off. 9/1, Near Tulsiyana Industrial Park Gram Kumedi, Indore – 453555 (MP) Tel: -0731-3501112 Email: compliance_officer@choksilab.in Website: www.choksilab.in C IN: L85195MP1993PLC007471 To, Date: 06th November,2026 The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Tower Dalal Street, Fort Mumbai-Maharashtra 400001 Ref: Scrip Code: 526546, ISIN: INE493D01013 Dear Sir, Subject: Intimation for Meeting of Directors pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015. Pursuant to Regulation 29(1) of the SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015 we are pleased to inform you that 05/2026-27 meeting of the Board of Directors of the Company has been scheduled to be held on Saturday, 14th day of November 2026 at 12.30 P.M. at the registered office of the Company to discuss the following; 1. To consider and approve the Unaudited Financial Result of the Company for the Quarter and half year ended on 30th September 2026; 2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting, which shall include at least one independent Director. If any. Further, in continuation to earlier disclosure dated 26.09.2026, regarding the closure of trading window w.e.f. 01st October, 2026 in pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Unaudited Financial Result for the quarter and half year ended 30th September, 2026 for all designated persons, their immediate relatives and all connected persons covered under the aforesaid code. You are requested to please take on record the above said information for your reference and further needful and disseminate on the website of the BSE. BY ORDER OF THE BOARD FOR CHOKSI LABORATORIES LIMITED PRAKHAR DUBEY Company Secretary & Compliance Officer M. No. F14327